¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"alveolar-arterial oxygen gradient"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • oxygen manifold
    »ê¼Ò¹èºÐÀåÄ¡
  • oxygen mask
    »ê¼Ò¸¶½ºÅ©
  • oxygen monitor
    »ê¼Ò°¨½Ã±â
  • oxygen room
    »ê¼Ò½Ç
  • oxygen saturation
    »ê¼ÒÆ÷È­µµ
  • oxygen tank
    »ê¼ÒÅë
  • oxygen tent
    »ê¼ÒÅÙÆ®
  • oxygen therapy
    »ê¼Ò¿ä¹ý
  • oxygen tolerance
    »ê¼Ò³»¼º
  • oxygen toxicity
    »ê¼Òµ¶¼º
  • saturation dissolved oxygen
    Æ÷È­¿ëÇØ»ê¼Ò·®
  • venous oxygen reserve
    Á¤¸Æ»ê¼Ò¿¹ºñ·Â
  • axial gradient
    üÃà±â¿ï±â, üÃà°æ»ç
  • active gradient shielding
    ´Éµ¿°æ»çÂ÷Æó
  • B1 field gradient
    ȸÀüÀÚÀå±â¿ï±â
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • oxygen electrode method
    »ê¼ÒÀü±Ø¹ý
  • oxygen
    »ê¼Ò
  • oxygen requirement
    »ê¼Ò¿ä±¸·®
  • oxygen room
    »ê¼Ò½Ç
  • oxygen saturation
    »ê¼ÒÆ÷È­µµ
  • oxygen tank
    »ê¼ÒÅë
  • oxygen tension
    »ê¼ÒºÐ¾Ð, »ê¼ÒÀå·Â
  • oxygen tent
    »ê¼ÒÅÙÆ®
  • oxygen enhancement ratio
    »ê¼ÒÈ¿°úÁõ°­·ü, »ê¼ÒÁõ°­ºñ
  • oxygen flush valve
    »ê¼ÒºÐÃâÆÇ¸·
  • saturation dissolved oxygen
    Æ÷È­¿ëÇØ»ê¼Ò·®
  • venous oxygen reserve
    Á¤¸Æ»ê¼Ò¿¹ºñ·Â
  • active gradient shielding
    ´Éµ¿±â¿ï±âÂ÷Æó, ´Éµ¿°æ»çÂ÷Æó
  • axial gradient
    üÃà±â¿ï±â, üÃà°æ»ç
  • gradient refocused acquisition
    ±â¿ï±âÀçÃÊÁ¡È¹µæ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Z gradient
    ZÃà °æ»ç
  • active gradient shielding
    ´Éµ¿ °æ»ç Â÷Æó
  • alveolar O2 pressure gradient
    ÆóÆ÷³» »ê¼Ò ºÐ¾ÐÂ÷.
  • frequency encoding gradient
    Á֯ļö ºÎȣȭ °æ»ç
  • gradient induced phase shift effect
    °æ»ç À¯µµ À§»ó º¯À§ È¿°ú
  • gradient limiting reabsorption
    ³óµµÁõ°¨Á¦ ÇѼº ÀçÈí¼ö.
  • gradient magnetic coil
    °æ»ç ÀÚ±â ÄÚÀÏ
  • gradient magnetic field
    °æ»ç ÀÚ±âÀå
  • gradient method
    °è´ÜÀû°Ë»ç¹ý
  • gradient moment
    °æ»ç ¸ð¸àÆ®
  • gradient moment nulling (GMN)
    °æ»ç ¸ð¸àÆ® ¹«È¿È­
  • gradient motion rephasing (GMR)
    °æ»ç ¿îµ¿ ÀçÀ§»ó
  • gradient recalled echo
    °æ»ç ȸº¹ ¿¡ÄÚ
  • gradient refocused acquisition
    °æ»ç ÀçÃÊÁ¡ ȹµæ
  • gradient refocused imaging
    °æ»ç ÀçÃÊÁ¡ ¿µ»ó
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • gradient acquisition imaging
    °æ»ç ȹµæ ¿µ»ó
  • gradient coil
    °æ»ç ÄÚÀÏ
  • gradient correction
    °æ»çµµ±³Á¤
  • gradient echo (GRE)
    °æ»ç ¿¡ÄÚ
  • gradient echo (GRE) imaging
    °æ»ç ¿¡ÄÚ ¿µ»ó
  • gradient echo (GRE) pulse sequence
    °æ»ç ¿¡ÄÚ ÆÞ½º ¿¬¼â
  • gradient echo effect
    °æ»ç ¿¡ÄÚ È¿°ú
  • gradient echo sequence
    °æ»ç ¿¡ÄÚ ¿¬¼â
  • gradient echo technique
    °æ»ç ¿¡ÄÚ¹ý
  • gradient echo technique magnetic susceptibility pro
    °æ»ç ¿¡ÄÚ¹ý ÀÚ±âÈ­À² ¾ç¼ºÀÚ ÀÌ¿Ï Áõ°­
  • gradient induced phase shift effect
    °æ»ç À¯µµ À§»ó º¯À§ È¿°ú
  • gradient limiting reabsorption
    ³óµµÁõ°¨Á¦ ÇѼº ÀçÈí¼ö.
  • gradient magnetic coil
    °æ»ç ÀÚ±â ÄÚÀÏ
  • gradient magnetic field
    °æ»ç ÀÚ±âÀå
  • gradient method
    °è´ÜÀû°Ë»ç¹ý
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • gradient-coupled active transport
    ±¸¹è(ÎþÛÕ) ¦Áø ´Éµ¿¼ö¼Û(ÒöÔÑâÃáê)
  • gradient curve
    ±¸¹è °î¼±(ÎþÛÕÍØàÊ)
  • gradient elution
    ±¸¹è ¿ë¸®(ÎþÛÕéÁ×î)
  • gradient-flow method
    ±¸¹è(ÎþÛÕ)-È帧¹ý(Ûö)
  • gradient gel electrophoresis
    ±¸¹è(ÎþÛÕ) Á© Àü±â¿µµ¿(ï³Ñ¨ç¶ÔÑ)
  • gradient layer
    ±¸¹èÃþ(ÎþÛÕöµ)
  • gradient mixer
    ±¸¹è È¥ÇÕ±â(ÎþÛÕûèùêÐï)
  • gradient plate technique
    ±¸¹è ÆÇ(ÎþÛÕ÷ù)¼ú(âú)
  • gradient sievorptive chromatography
    ±¸¹è ¿©°úÈíÂø(ÎþÛÕÕëΦýåó·) Å©·Î¸¶Åä±×·¡ÇÇ
  • isokinetic gradient
    µî¿ªÇÐ ±¸¹è(ÔõÕôùÊÎøÛÎ)
  • isopycnic gradient centrifugation
    µî¹Ðµµ±¸¹è¿ø½ÉºÐ¸®(ÔõÚËÓøÎøÛÎêÀãýÝÂ×î)
  • linear density gradient
    ¼± ¹Ðµµ(à»ÚËÓø)±â¿ï±â
  • pH gradient electrophoresis
    pH ±¸¹è Àü±â¿µµ¿(ÎþÛÕï³Ñ¨ç¶ÔÑ)
  • potential gradient
    "ÀüÀ§ ±¸¹è(ï³êÈÎþÛÕ), ÆÛÅÙ¼È ±¸¹è(ÎþÛÕ)"
  • preformed gradient isodensity centrifugation
    ±âÇü¼º ±¸¹è(Ðþû¡à÷ÎþÛÕ) ¾ÆÀ̼ҹеµ ¿ø½ÉºÐ¸®(ÚËÓøêÀãýÝÂ×î)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • gradient moment nulling [=GMN]
    °æ»ç¸ð¸àÆ®¹«È¿È­
  • gradient motion rephasing [=GMR]
    °æ»ç¿îµ¿ÀçÀ§»ó
  • gradient recalled echo
    °æ»çȸº¹¿¡ÄÚ
  • gradient refocused acquisition
    °æ»çÀçÃÊÁ¡È¹µæ
  • gradient refocused imaging
    °æ»çÀçÃÊÁ¡¿µ»ó
  • gradient shielding
    °æ»çÂ÷Æó
  • gradient slope
    °æ»ç±â¿ï±â
  • gradient spoiling
    °æ»çȸ¼Õ
  • imaging gradient
    ¿µ»ó°æ»ç(ÀÚ°è)
  • magnetic field gradient
    ÀÚÀå°æ»ç
  • magnetic field gradient vector
    ÀÚÀå°æ»çº¤ÅÍ
  • magnetic susceptibility gradient
    ÀÚ±âÈ­À²°æ»ç
  • magnetization prepared rapid acquisition gradient echo
    ÀÚÈ­Áغñ°í¼Ó°æ»ç¿¡ÄÚ È¹µæ
  • maximum gradient strength
    ÃÖ´ë°æ»ç°­µµ
  • motion compensation gradient
    ¿îµ¿º¸»ó°æ»ç
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
ECPOG electrochemical potential gradient
GE gastric empyting; gastroemotional; gastroenteritis; gastroenterology; gastroenterostomy; gastroesoph...
GEPG gastroesophageal pressure gradient
GGE generalized glandular enlargement; gradient gel electrophoresis
GMN gradient moment nulling
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
NEPHGE Nonequilibrium pH gradient electrophoresis
PCR-DGGE Polymerase chain reaction-denaturing gradient gel electrophoresis
PFG Pulse field gradient
PGSE Pulsed Gradient Spin Echo
SAAG Serum-Ascites Albumin Gradient
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • oxygen coefficient
    »ê¼Ò °è¼ö
  • oxygen demand
    »ê¼Ò ÇÊ¿ä, »ê¼Ò Çʿ䷮, »ê¼Ò ¿ä±¸·®
  • oxygen deprivation
    »ê¼Ò °áÇÌ, »ê¼Ò ºÎÁ·
  • oxygen dissociation curve
    »ê¼Ò ÇØ¸® °î¼±
  • oxygen lack
    »ê¼Ò ºÎÁ·, »ê¼Ò °áÇÌ
  • oxygen poisoning
    »ê¼Ò Áßµ¶, »ê¼Ò Áßµ¶Áõ
    °í³óµµ »ê¼ÒÀÇ Àå±â°£ ÈíÀÔÀ¸·Î »ý±â´Â Æó ½ÇÁúÀÇ ½ÉÇÑ Àå¾Ö.
  • oxygen probe
    »ê¼Ò Žħ
  • oxygen reserve
    »ê¼Ò ¿¹ºñ
  • oxygen saturaon curve
    »ê¼Ò Æ÷È­ °î¼±
  • oxygen secretion
    »ê¼Ò ºÐºñ
  • oxygen supply equipment
    »ê¼Ò °ø±Þ ÀåÄ¡
  • oxygen tension
    »ê¼Ò Àå·Â
  • oxygen toxicity
    »ê¼Ò µ¶¼º
  • oxygen transport mechanism
    »ê¼Ò ¿î¹Ý ±âÀü
  • oxygen uptake
    »ê¼Ò ¼·Ãë, »ê¼Ò ¼·Ãë·®
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
critical dissolved oxygen concentration <biology> The minimum concentration of oxygen in the water needed for the growth of a culture which has been submerged, where oxygen is the limiting factor to the growth of the culture.
(09 Oct 1997)
heavy oxygen A stable oxygen isotope making up 0.20% of natural oxygen; used in mass spectrometry and in NMR studies of tissue.
Synonym: heavy oxygen.
(05 Mar 2000)
home oxygen therapy A form of oxygen that is typically delivered via nasal cannula. Commonly provided to those with severe heart or lung disease.
See: chronic obstructive pulmonary disease.
(27 Sep 1997)
hyperbaric oxygen High pressure oxygen, oxygen at a pressure greater than 1 atmosphere.
See: hyperbaric oxygenation.
Singlet oxygen, an excited or higher energy form of oxygen characterised by the spin of a pair of electrons in opposite directions, whereas electron spin is unidirectional in normal molecular oxygen Because of its great reactivity, singlet oxygen is a probable intermediate in most photo-oxidation reactions. Although it exists for no more than 0.1 sec, it may react with atmospheric pollutants to foster smog formation and may have harmful biological effects.
Triplet oxygen, the normal unexcited state of O2 in the atmosphere, in which the unpaired pair of electrons are so displaced that their magnetic fields are oriented in the same direction, resulting in paramagnetism; each of the heat-generated spectral lines of such oxygen can be split by a magnetic field into a triplet.
Compare: singlet oxygen.
(05 Mar 2000)
hyperbaric oxygen therapy <physiology> A pressurised chamber that allows for the delivery of oxygen in higher concentrations for therapeutic benefit.
Useful in the treatment of severe burns, peripheral vascular disease, carbon monoxide poisoning and decompression illness.
(04 Mar 1998)
singlet oxygen An energised but uncharged form of oxygen that is produced in the metabolic burst of leucocytes and that can be toxic to cells.
(18 Nov 1997)
dissolved oxygen <biochemistry> The concentration of oxygen dissolved in water, expressed in mg/l or as percent saturation, where saturation is the maximum amount of oxygen that can theoretically be dissolved in water at a given altitude and temperature.
(11 Jan 1998)
oxygen 1. <chemistry> A colourless, tasteless, odorless, gaseous element occurring in the free state in the atmosphere, of which it forms about 23 per cent by weight and about 21 per cent by volume, being slightly heavier than nitrogen. Symbol O. Atomic weight 15.96.
It occurs combined in immense quantities, forming eight ninths by weight of water, and probably one half by weight of the entire solid crust of the globe, being an ingredient of silica, the silicates, sulphates, carbonates, nitrates, etc.
Oxygen combines with all elements (except fluorine), forming oxides, bases, oxyacid anhydrides, etc, the process in general being called oxidation, of which combustion is only an intense modification.
at ordinary temperatures with most substances it is moderately active, but at higher temperatures it is one of the most violent and powerful chemical agents known. It is indispensable in respiration, and in general is the most universally active and efficient element.
It may be prepared in the pure state by heating potassium chlorate. This element (called dephlogisticated air by Priestley) was named oxygen by Lavoisier because he supposed it to be a constituent of all acids. This is not so in the case of a very few acids (as hydrochloric, hydrobromic, hydric sulphide, etc), but these do contain elements analogous to oxygen in property and action. Moreover, the fact that most elements approach the nearer to acid qualities in proportion as they are combined with more oxygen, shows the great accuracy and breadth of Lavoisier's conception of its nature.
Pharmacologic action: Increases the supply of oxygen to ischemic tissues. It is the most effective agent in emergency cardiac care.
Uses: Always administer oxygen during emergency cardiac care.
Dose: Nasal cannula with oxygen flow of 4 liters per minute provides FiO2 of about 30%. Nasal cannula with oxygen flow of 6-8 liters per minute provides FiO2 of 35-40%. Venturi mask can provide higher and more precise oxygen concentrations.
Potential complications: Ensure that oxygen is being delivered. Carefully check all connections. Oxygen toxicity develops only after several days of exposure to high FiO2. Increased FiO2 may cause hypoventilation in COPD patients dependent on hypoxic ventilatory drive. This is very rare and simply requires starting at lower FiO2, careful observation, and assisted ventilation if necessary.
Origin: F. Oxygene, from Gr. Sharp, acid + root of to be born. So called because originally supposed to be an essential part of every acid.
(17 Mar 2000)
oxygen-15 A cyclotron-produced, positron-emitting radioisotope of oxygen with a half-life of 122.2 seconds; used in studies of respiratory function and in positron emission tomography.
(05 Mar 2000)
oxygen-16 The common oxygen isotope, making up 99.76% of natural oxygen.
(05 Mar 2000)
oxygen-17 The rarest of the stable oxygen isotopes, making up 0.04% of natural oxygen.
(05 Mar 2000)
oxygen-18 A stable oxygen isotope making up 0.20% of natural oxygen; used in mass spectrometry and in NMR studies of tissue.
Synonym: heavy oxygen.
(05 Mar 2000)
oxygen affinity anoxia Anoxia due to inability of haemoglobin to release oxygen.
(05 Mar 2000)
oxygen affinity hypoxia Hypoxia due to reduced ability of haemoglobin to release oxygen.
(05 Mar 2000)
oxygen capacity The maximum quantity of oxygen that will combine chemically with the haemoglobin in a unit volume of blood; normally it amounts to 1.34 ml of O2 per gm of Hb or 20 ml of O2 per 100 ml of blood.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á